Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

University of Victoria

$25,000.00

Fabrication of vascularized organoids for regenerative medicine and drug discovery

EF 2018-19

Résumé
The ever-increasing demand for organ repair and transplantation and the unmet need for developing in vitro*models that mimic the complexities of native organs for drug discovery have led to several innovative that*enable the bioengineering of organ-like constructs. Organoids, which are three-dimensional (3D) cell cultures*that incorporate some of the critical features of the represented organ, are frequently used for such applications.*These in vitro culture systems contain a self-renewing stem cell population which differentiates into multiple,*organ-specific cell types that exhibit spatial organization similar to the corresponding organ and are capable of*recapitulating some functions of that organ providing a highly physiologically relevant system. However, the*use of organoids has been limited to small dimensions (<1 mm) due to the limitations imposed by mass*transport in larger organoids. Laboratory-engineered tissues with dimensions greater than a few hundred*micrometers require an internal vascular supply to attain clinically significant viable cell densities. This*short-term project aims to develop millimeter size organoids of human induced pluripotent stem cells (hiPSCs)*with micropores as vasculatures for enhanced mass transport within the organoid structure. We will use a*microfluidic system to fabricate hydrogel micro-rods that will be mixed with the cells during the organoid*formation and will provide a vascular-like construct that will enhance the transport of oxygen and nutrients*within the organoid. We will perform a systematic characterization study to develop a protocol for the*fabrication of the micro-rods and will incorporate them in organoids in collaboration with STEMCELL*technologies. The proposed research program will result in numerous and far-reaching benefits concerning the*Canadian economy, Canada's international reputation for life science research and innovation, and the quality*of Canadian's life. Moreover, as the rapidly growing fields of stem cells and regenerative medicine have a very*high research and development demand globally, it is essential to conduct innovative research and train*personnel in these areas, ensuring that Canada remains a leader in these cutting-edge fields.
Programme
Engage Grants Program
Emplacement
British Columbia, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
529756-2018
Name nom
Akbari, Mohsen
Department département
Mechanical Engineering
Organization id
7
Institution établissement
University of Victoria
Province en
British Columbia
Province fr
Colombie-Britannique
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1554
Committee name en
Pacific Internal Decision Committee
Committee name fr
Comité de décision interne pour le Pacifique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
1
Nb partie
1
Application title
Fabrication of vascularized organoids for regenerative medicine and drug discovery
Keyword
NSERC
Application summary
The ever-increasing demand for organ repair and transplantation and the unmet need for developing in vitro*models that mimic the complexities of native organs for drug discovery have led to several innovative that*enable the bioengineering of organ-like constructs. Organoids, which are three-dimensional (3D) cell cultures*that incorporate some of the critical features of the represented organ, are frequently used for such applications.*These in vitro culture systems contain a self-renewing stem cell population which differentiates into multiple,*organ-specific cell types that exhibit spatial organization similar to the corresponding organ and are capable of*recapitulating some functions of that organ providing a highly physiologically relevant system. However, the*use of organoids has been limited to small dimensions (<1 mm) due to the limitations imposed by mass*transport in larger organoids. Laboratory-engineered tissues with dimensions greater than a few hundred*micrometers require an internal vascular supply to attain clinically significant viable cell densities. This*short-term project aims to develop millimeter size organoids of human induced pluripotent stem cells (hiPSCs)*with micropores as vasculatures for enhanced mass transport within the organoid structure. We will use a*microfluidic system to fabricate hydrogel micro-rods that will be mixed with the cells during the organoid*formation and will provide a vascular-like construct that will enhance the transport of oxygen and nutrients*within the organoid. We will perform a systematic characterization study to develop a protocol for the*fabrication of the micro-rods and will incorporate them in organoids in collaboration with STEMCELL*technologies. The proposed research program will result in numerous and far-reaching benefits concerning the*Canadian economy, Canada's international reputation for life science research and innovation, and the quality*of Canadian's life. Moreover, as the rapidly growing fields of stem cells and regenerative medicine have a very*high research and development demand globally, it is essential to conduct innovative research and train*personnel in these areas, ensuring that Canada remains a leader in these cutting-edge fields.